The preparing method of inactivation vaccine of swine erysipelas treated with inactivation swine complement against antigen
KR20080081500A
The polysaccharide improving immunity of animal from candida spp., and its preparing method
KR20080081499A
The polysaccharide improving immunity of animal from saccharomyces spp., and its preparing method
KR20070077587A
Erysipelothrix rhusiopathiae culture medium without animal serum and swine erysipelas live and killed vaccine prepared with the bacteria cultured on that medium
KR20070077589A
Inactivation vaccine using the gel-adjuvant adsorbed with specific antibody against antigen, complements or immunostimulants or antigen treated with specific antibody against antigen or complements
KR20070077588A
Swine erysipelas killed vaccine prepared with inactivated bacterial culture and protective protein antigen of e. rhusiopathiae
KR20070077586A
Live vaccine using diluent added gel or gel adsorbed with immunostimulants
KR20060075483A
Method for diagnosis of theileria disease using recombinant p33 protein coated to latex bead
KR20050082512A
Kit for diagnosis of foot-and-mouth disease containing peptide of 2c and 3b nonstructural protein of foot-and-mouth disease virus
KR20040051199A
Detection kit for the classical swine fever antibody using immunochromatography method
KR20040047484A
Recombinant porcine adenovirus type 3 expressing japanese encephalitis virus gene ns1 and use thereof
KR20040047483A
DNA vaccine using Japanese encephalitis virus and porcine immunoregulatory genes, and method of using the same
KR20040047485A
Recombinant porcine adenovirus type 3 expressing japanese encephalitis virus gene prme and use thereof
KR20030053857A
Fusion protein having the enhanced immunogenecity to bovine theilerosis, and preparation process and use thereof
KR20030053856A
Attenuated vaccine for bovine theileriosis
KR100267748B1
Method for purification of porcine transmissible coronavirus
